 ATLANTA, Nov. 05, 2020 GLOBE NEWSWIRE -- DLH Holdings Corp. NASDAQ: DLHC DLH or the Company, a leading provider of innovative healthcare research, services and solutions to the federal government, today announced Sandra Halverson, MPH, PhD has been appointed Chief Scientist effective November 1, 2020. In this role, Dr. Halverson will work collaboratively with the DLH Executive Leadership Team to help set company research and scientific priorities. In addition to research coordination and personnel management duties, Sandra will serve as a public representative of the company, helping tell the story of DLHs increasingly prominent role in the public health and life sciences market space. 